ArticleSignal transduction and targeted therapy2026
EBV-driven Gate-License-Amplify circuit in multiple sclerosis pathogenesis.
Yuxin Li, Xiaofei Shi, Yuxiao Zhang, Mu-Sheng Zeng, Qian Zhong, Wanli Liu
Abstract read
In one paragraphArticle in Signal transduction and targeted therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
6 authors.
Xiaofei Shi *Department of Rheumatology and Immunology, The First Affiliated Hospital, College of Clinical Medicine, Henan University of Science and Technology, Luoyang, China.
Yuxiao ZhangState Key Laboratory of Membrane Biology, School of Life Sciences, Tsinghua-Peking Center for Life Sciences, Institute for Immunology, Ministry of Education Key Laboratory of Protein Sciences, Tsinghua University, Beijing, China.
Mu-Sheng ZengState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Department of Experimental Research, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, China.ORCID http://orcid.org/0000-0003-3509-5591 Qian ZhongState Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Department of Experimental Research, Sun Yat-sen University Cancer Center, Sun Yat-sen University, Guangzhou, China. zhongqian@sysucc.org.cn.ORCID http://orcid.org/0000-0003-1071-6996 Wanli LiuState Key Laboratory of Membrane Biology, School of Life Sciences, Tsinghua-Peking Center for Life Sciences, Institute for Immunology, Ministry of Education Key Laboratory of Protein Sciences, Tsinghua University, Beijing, China. LiuLab@Tsinghua.edu.cn.ORCID http://orcid.org/0000-0003-0395-2800 Funding
National Natural Science Foundation of China (National Science Foundation of China) 32430035National Natural Science Foundation of China (National Science Foundation of China) 32441097Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation) Z230014
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Identifiers
PMID42595750
PMCPMC13473120
What OpenQuestion holds
Textmetadata
Read underepoch 390